D. Staworn et al., BRAIN-DEATH IN PEDIATRIC INTENSIVE-CARE UNIT PATIENTS - INCIDENCE, PRIMARY DIAGNOSIS, AND THE CLINICAL OCCURRENCE OF TURNERS TRIAD, Critical care medicine, 22(8), 1994, pp. 1301-1305
Objectives: To determine the incidence and characteristics of children
with brain death in the pediatric intensive care unit (ICU), and to a
ssess the incidence of the clinical triad (Turner's triad) of central
diabetes insipidus, low glucose demand, and low CO2 production. Design
: Retrospective review of medical records. Setting: Two multidisciplin
ary pediatric ICUs. Patients: Medical records of pediatric patients de
clared brain dead and admitted to two multidisciplinary pediatric ICUs
. Measurements and Main Results: Patient records were reviewed for dem
ographic data, primary diagnosis, severity of illness (Pediatric Risk
of Mortality score and calculated risk of mortality), methods by which
brain-death diagnosis was determined, presence of central diabetes in
sipidus, low glucose demand, low CO2 production in the final 24 hrs be
fore the diagnosis was made, and whether organ donation was accomplish
ed. The incidence of brain death among all patients admitted to the pe
diatric ICUs was 0.9%, accounting for 11% of patients who died during
the same period. The most common presentation leading to brain-death d
iagnoses was trauma, followed by drowning/near drowning, and meningiti
s. The majority of brain-death diagnoses were made using both clinical
criteria and confirmatory tests (66%). The incidence of clinical sign
s of Turner's triad was 41% for central diabetes insipidus, 49% for lo
w glucose demand, and 53% for low CO2 production. Two of the three fea
tures were present in 38% of patients, and 12% of the patients had all
three features. Conclusions: Our series of brain-dead patients in the
pediatric ICU showed a 0.9% incidence of brain death. The most common
primary diagnosis was trauma, a finding that is similar to other seri
es. We also demonstrated that the clinical triad (Turner's triad) is p
resent in this patient population, although only 12% of study patients
demonstrated all three features.